Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?

To: David Graham who wrote (791)	3/18/1998 8:37:00 PM
From: seminole	Respond to of 1826

David <<Anybody else hear rumor of a license agreement for Europe for 114?>> I have hear nothing. I am particularly greedy today and hope for $60M. Maybe less if the partner pays for MGI's Phase II trials. Hey partner, pay them now or pay more latter richard

To: David Graham who wrote (791)	3/18/1998 9:27:00 PM
From: Robert van Royen	Read Replies (2) \| Respond to of 1826

My spies tell me that the European license deal will definitely be announced before the Annual Meeting in May. My gut feeling is that we might be surprised much earlier. But remember I am a tremendous optimist and probably give management more credit than they probably deserve. Hey, I would rather be a believer than a pessimist. Remember I bought another couple of thousand shares yesterday. Gosh,just thinking about the possibilities I wish the Market was still open......